Apheresis Equipment Market By Product Type 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Apheresis Equipment Market
Apheresis Equipment Market: By Product Type (Equipment for Donor Apheresis Equipment & Therapeutics Apheresis Equipment), By Disease(Neurological, Blood, Cardiovascular Disorders, Other Disorders), By Procedure(TPE, ECI, Others) & Geography-Forecast (2016-2021)
Report Code : HCR 0157
Updated Date: 29 February, 2016  

  • Report Description
  • Table of Contents
  • Customization Options
1. Apheresis Equipment – Market Overview
2. Executive Summary
3. Apheresis Equipment Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. Apheresis Equipment – Market Forces
   4.1. Drivers
      4.1.1. Growing prevalence for blood disorders and increasing demand for blood & blood components
      4.1.2. Increasing demand for therapeutic Apheresis Equipment in cancer treatment
   4.2. Restraints
      4.2.1.  Lack of awareness among patients
   4.3. Opportunities
   4.4. Challenges
      4.4.1. High cost of Apheresis Equipment
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Apheresis Equipment Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Apheresis Equipment Market, By Product Type
   6.1. Equipment for Donor Apheresis Equipment
   6.2. Equipment for Therapeutics Apheresis Equipment
7. Apheresis Equipment Market, By Disease
   7.1. Neurological Disorders
   7.2. Blood Disorders
   7.3. Cardiovascular Disorders
   7.4. Renal Disorders
   7.5. Autoimmune Disorders
   7.6. Metabolic Disorders
   7.7. Other Disorders
8. Apheresis Equipment Market, By Procedure
   8.1. Therapeutic Plasma Exchange (TPE)
   8.2. Therapeutic CytApheresis Equipment
   8.3. Photopheresis
   8.4. Extracorporeal Immunoadsorption (ECI)
   8.5. Low-Density Lipoprotein (LDL) Apheresis Equipment
9. Apheresis Equipment Market, By Geography
   9.1. Europe
      9.1.1. Germany
      9.1.2. France
      9.1.3. Italy
      9.1.4. Spain
      9.1.5. Russia
      9.1.6. U.K.
      9.1.7. Rest of Europe
   9.2. Asia Pacific
      9.2.1. China
      9.2.2. India
      9.2.3. Japan
      9.2.4. South Korea
      9.2.5. Rest of Asia-Pacific
   9.3. North America
      9.3.1. U.S.
      9.3.2. Canada
      9.3.3. Mexico
   9.4. Rest of the World (RoW)
      9.4.1. Brazil
      9.4.2. Rest of RoW
10. Apheresis Equipment – Market Entropy
   10.1. Expansion
   10.2. Technological Developments
   10.3. Merger & Acquisitions, and Joint Ventures
   10.4. Supply- Contract
11. Company Profiles
   11.1. Asahi Kasei Kuraray Medical Co Ltd. 
      11.1.1.  Introduction
      11.1.2. Financials
      11.1.3. Key Insights
      11.1.4. Key Strategy
      11.1.5. Product Portfolio
      11.1.6. SWOT Analysis
   11.2. B. Braun Melsungen AG 
      11.2.1. Introduction
      11.2.2. Financials
      11.2.3. Key Insights
      11.2.4. Key Strategy
      11.2.5. Product Portfolio
      11.2.6. SWOT Analysis
   11.3. Kawasumi Laboratories Inc.    
      11.3.1.  Introduction
      11.3.2. Financials
      11.3.3. Key Insights
      11.3.4. Key Strategy
      11.3.5. Product Portfolio
      11.3.6. SWOT Analysis
   11.4. Terumo BCT Inc.   
      11.4.1. Introduction
      11.4.2. Financials
      11.4.3. Key Insights
      11.4.4. Key Strategy
      11.4.5. Product Portfolio
      11.4.6. SWOT Analysis
   11.5. Haemonetics Corporation
      11.5.1. Introduction
      11.5.2. Financials
      11.5.3. Key Insights
      11.5.4. Key Strategy
      11.5.5. Product Portfolio
      11.5.6. SWOT Analysis
   11.6. Nikkiso Co., Ltd.
      11.6.1. Introduction
      11.6.2. Financials
      11.6.3. Key Insights
      11.6.4. Key Strategy
      11.6.5. Product Portfolio
      11.6.6. SWOT Analysis
   11.7. Cerus Corporation
      11.7.1. Introduction
      11.7.2. Financials
      11.7.3. Key Insights
      11.7.4. Key Strategy
      11.7.5. Product Portfolio
      11.7.6. SWOT Analysis
   11.8. Fresenius Se & Co. KGAA
      11.8.1. Introduction
      11.8.2. Financials
      11.8.3. Key Insights
      11.8.4. Key Strategy
      11.8.5. Product Portfolio
      11.8.6. SWOT Analysis
   11.9. Medica S.P.A
      11.9.1. Introduction
      11.9.2. Financials
      11.9.3. Key Insights
      11.9.4. Key Strategy
      11.9.5. Product Portfolio
      11.9.6. SWOT Analysis
   11.10. Kaneka Corporation
      11.10.1. Introduction
      11.10.2. Financials
      11.10.3. Key Insights
      11.10.4. Key Strategy
      11.10.5. Product Portfolio
      11.10.6. SWOT Analysis
*More than 10 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
12. Appendix
   12.1. Abbreviations
   12.2. Sources
   12.3. Research Methodology
   12.4. Bibliography
   12.5. Compilation of Expert Insights
   12.6. Disclaimer
Apheresis is a process which involves removal of whole blood from a patient or donor. Apheresis equipment is a machine which is used to remove the blood and is designed as a centrifuge, the components of whole blood are separated. One of the separated portion of the blood is withdrawn while re-transfusing the other portion. Global demand for such machines is expected to grow significantly and is expected to be driven by factors such as increasing instances of blood disorders and growing demand for blood and blood components.

This report identifies the apheresis equipment market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to apheresis equipment market.

Apheresis Equipment Market

Globally North America dominated the market for apheresis equipment in 2015 and is expected to continue its dominance during the period of study due to higher usage and adoption of advanced medical technologies. North America was followed by Europe and Asia-Pacific as the second and third largest markets respectively for apheresis equipment in 2015. Demand for apheresis equipment in Asia-Pacific is expected to witness fastest growth in the near future due to constantly growing demand of blood components for transfusion from increasing surgical procedures and higher accidents & trauma cases, rapid development in the healthcare infrastructure in the region.

This report on global apheresis equipment is segmented on the basis of various types of apheresis equipment by product type, by disease, by procedure type and market size in various geographical regions.
  • On the basis of product types report classified as follows covering all major types of apheresis equipment as follows: Equipment for Donor Apheresis Equipment and Equipment for Therapeutics Apheresis Equipment
  • On the basis of disease treated, this report is segmented as follows covering all the major type of treated disease as follows:  Neurological Disorders, Blood Disorders, Cardiovascular Disorders, Renal Disorders, Autoimmune Disorders, Metabolic Disorders and Other Disorders
  • On the basis of procedure followed, global apheresis equipment market is segmented as follows covering all major procedures used: Therapeutic Plasma Exchange (TPE), Therapeutic CytApheresis Equipment, Photopheresis, Extracorporeal Immunoadsorption (ECI), Low-Density Lipoprotein (LDL) Apheresis Equipment
  • This is report has been further segmented into major regions, which includes detailed analysis of each region such as North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for apheresis equipment in each of the region.

Sample Companies Profiled in this Report are: 
  • Asahi Kasei Kuraray Medical Co Ltd. 
  • B. Braun Melsungen AG 
  • Kawasumi Laboratories Inc.    
  • Terumo BCT Inc.   
  • Haemonetics Corporation
  • 10+
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports